B and T Lymphocyte Associated (BTLA) (C-Term) Peptide
-
- Target See all BTLA products
- BTLA (B and T Lymphocyte Associated (BTLA))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SRPWLLYSLL PLGGLPLLIT TCFCLFCCLR RHQGKQNELS DTAGREINLV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BTLA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Synonyms
- BTLA Peptide, BTLA1 Peptide, CD272 Peptide, A630002H24 Peptide, B and T lymphocyte associated Peptide, BTLA Peptide, Btla Peptide
- Background
-
This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
Alias Symbols: BTLA1, CD272, FLJ16065, MGC129743
Protein Interaction Partner: PTPN11,PTPN6,TNFRSF14,VTCN1,PTPN11
Protein Size: 289 - Molecular Weight
- 32 kDa
- Gene ID
- 151888
- NCBI Accession
- NM_181780, NP_861445
- UniProt
- Q7Z6A9
-